The ACR places a high priority on any policy or regulation that impacts drug pricing, the cost of providing high quality care and/or patient access to vital therapies. For further information about the ACR’s regulatory advocacy efforts, email the ACR’s advocacy team at [email protected]. ACR/ARP members can also schedule a time to meet directly with the ACR’s advocacy team to discuss issues and challenges you are facing.
Key Takeaways
- The European Union/U.S. trade deal includes a 15% tariff that applies to pharmaceuticals.
- The tariffs could impact the cost of providing care, patient access to therapies and drug research and development.
- More tariffs on pharmaceuticals may be coming.